Accra, May 22, GNA - Ghana has recorded 53 new recoveries from COVID-19, bringing the current cumulative number to 1,951.
The cumulative number of case count as at Friday, May 22, 2020, has also risen to 6,486, which is an increase of 217 new cases and this represents a positivity rate of 3.39 per cent, from the 6,269 recorded by the Ghana Health Service (GHS) in its last update, however the death toll still remains 31 persons.
On the case count per region, the GHS official platform for COVID-19 still shows Greater Accra leading with 4,699 cases, followed by Ashanti-988; Central-287; Western-195 and Eastern Region-106 cases.
The rest are the Western North-57; Volta -44; Northern-34; Oti-26; Upper East-26; Upper West-21; North East-two, with the Bono Region recording a single case.
Meanwhile, the three regions made up of the Savannah, Bono East and Ahafo, out of the 16 others, have still maintained their COVID-19-free status for yet another week.
A further breakdown in the changes of cases of COVID-19 in the country, the GHS said between May 19 and May 20, a total of 117 new cases of COVID-19 were recorded by the Greater Accra, two from Central, Western-25, Volta-3, Ashanti-67, and Northern-3, leaving the remaining regions with no new record of infections.
Again on treatment outcomes, Ghana currently has 12 patients with severe conditions, of which four were being treated at the University of Ghana Medical Centre, two at the Ga East Municipal Hospital, one at Ho, three at Korle- Bu and two at the 37 Military Hospital; and in all the cases there are currently none on a ventilator.
A cumulative of 192,194 samples has so far been tested for their first results, compared to the 191,213 persons tested for the second.
The GHS has maintained its emphasis on the "Stay at Home", regular hand washing with soap under running water or with alcohol- based sanitiser, observing the cough and sneezing etiquettes, stressing on social distancing and wearing of face masks, among other measures as the way to win the fight against COVID-19.